Xeomin 50 [USP'U]/1
incobotulinumtoxinA · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Merz North America, Inc.
Xeomin is a injection, powder, lyophilized, for solution containing incobotulinumtoxina at 50 [USP'U]/1, taken intramuscular. Manufactured by Merz North America, Inc..
Key Facts
- Brand Name
- Xeomin
- Generic Name
- incobotulinumtoxinA
- NDC Code (Product)
46783-165- Manufacturer
- Merz North America, Inc.
- Strength
- 50 [USP'U]/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125360
- Drug Class
- Acetylcholine Release Inhibitor [EPC]; Neuromuscular Blocker [EPC]
- Marketing Start
- 08/01/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is Xeomin used for?
Xeomin contains incobotulinumtoxinA. It is a injection, powder, lyophilized, for solution taken intramuscular. Consult your doctor for specific uses.
Is Xeomin a controlled substance?
Xeomin is not classified as a controlled substance by the DEA.
What is the generic name for Xeomin?
The generic name for Xeomin is incobotulinumtoxinA. There are no other listed brand versions of incobotulinumtoxinA.
What is the NDC code for Xeomin 50 [USP'U]/1?
The NDC (National Drug Code) for Xeomin 50 [USP'U]/1 is 46783-165, listed by Merz North America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)